Authors
Rebecca Khan, MD, FACOG, practiced obstetrics and gynecology for 21 years before serving as the director of women’s health for BioReference® Laboratories, LLC. Currently, Khan works in medical affairs at Thermo Fisher Scientific with a focus on placental biomarkers, sFlt-1 and PlGF.
Siva Namasivayam is the CEO of Cohere Health, a clinical intelligence company that aligns physicians and health plans on evidence-based care paths for the patient’s entire care journey. Prior to co-founding Cohere, Siva was a founding partner of SCIO Health Analytics, which served over 50 Fortune 500 clients. His experience includes serving as SVP, chief revenue officer at MphasiS; SVP, payer services at Dell; and senior software engineer at Intel. Siva received his bachelor’s degree from the National Institute of Technology in Tiruchirappalli, India. He holds a master’s in computer science from the University of Pittsburgh and an MBA from the University of Michigan.